SCHEMBL4451980

SCHEMBL4451980

O=CCC(O)c1ncc[nH]1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FPR2 P25090 4/20 0.36
F2RL1 P55085 15/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10696546 0.78 FPR2 (0.38) FPR2F2RL1
SCHEMBL395971 0.76
SCHEMBL4682202 0.75
SCHEMBL5693242 0.75
SCHEMBL17282910 0.75
SCHEMBL2382328 0.75
SCHEMBL28913437 0.75
SCHEMBL19547890 0.74 TBXAS1 (0.40) FPR2F2RL1
SCHEMBL1118032 0.74 FPR2 (0.34) FPR2F2RL1
SCHEMBL11127820 0.72 F2RL1 (0.46) FPR2F2RL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114438-A1 AN INSULINOTROPIC COMPLEX USING AN IMMUNOGLOBULIN FRAGMENT Hanmi Pharmaceutical. Co., Ltd. (KR) 2009-11-11 EP disclosed
WO-2008082274-A1 AN INSULINOTROPIC COMPLEX USING AN IMMUNOGLOBULIN FRAGMENT HANMI PHARMACEUTICAL CO., LTD. (KR) 2008-07-10 WO disclosed